INSIGHTS ON CLINICAL TRIAL PARTNERING

• Fast-Track Innovation, Address CMC Challenges In Expedited Pathways

  Learn to overcome solubility challenges and utilize flexible development strategies to transition innovative treatments from early-phase trials to commercialization while ensuring patient safety.

• Breaking Barriers: Enhancing The Bioavailability Of Orally Delivered TPDs

  The large, bulky structure of TPDs limits solubility and permeability. Enabling technologies like spray drying, hot melt extrusion, and nanomilling are key to formulating these challenging molecules.

• Early Phase Clinical Trial Enrollment: How To Avoid Delays From The Start

  By operationalizing the early-phase strategies discussed in this article, trial teams can ensure that foundational safety and efficacy data are captured without the delays that derail studies.

• 5 Projections For 2026: Navigating The New Normal In Clinical Trials

  In 2026, clinical trial success depends on moving from AI hype to proven utility. Unified data and seamless site experiences are no longer optional; they are the keys to trial resilience.

• Rethinking Trial Access Through Trust-Driven Design And Local Collaboration

  5/19/2026

  Locally embedded research models help sponsors reach underserved populations while reducing burden on patients and health systems alike.

• RTSM Software Isn't One-Size-Fits-All, Especially For Small Biotechs

  5/13/2026

  Smaller biotech companies often have very different clinical trial needs than large pharmaceutical organizations, and that includes RTSM.

• Flexible Packaging, Labeling And Distribution For Diverse Drug Types

  3/24/2026

  Learn how demand-led and hybrid clinical supply models reduce waste, accelerate timelines, and improve flexibility for global trials through regional hubs and patient-specific packaging strategies.

• Choosing RTSM? Evaluate The Team Running It, Not Just The Software

  2/25/2026

  High-performing RTSM requires more than just code. Discover why team continuity and clinical expertise are the most overlooked factors in reducing trial risk and ensuring regulatory compliance.

• How To Select The Right Bioanalysis CRO For Your Program

  11/3/2025

  The right bioanalysis CRO accelerates progress, while the wrong one can derail outcomes. When every provider claims speed and credibility, how do you confidently choose the right partner?